Cancer
The prostate cancer androgen receptor cistrome in African American men associates with upregulation of lipid metabolism and immune response
African American (AA) men are more likely to be diagnosed with and die from prostate cancer (PCa) than European American (EA) men. Despite the cent...
A first look at breast cancer screening in over 1000 community health centers in the United States
Community Health Centers (CHCs) primarily serve low-income and vulnerable patients. Breast cancer screening recently became a quality-of-care metri...
Factors associated with enrolment in clinical trials among women with early-stage breast cancer
Background:
Clinical trials allow development of innovative treatments and ameliorate the quality of clinical care in oncology. Data...
Early-Onset Pancreatic Cancer Increased in White and Hispanic Women
Between 1995 and 2018, non-Hispanic White and Hispanic women in the United States experienced the greatest increases in early-onset pancreatic canc...
Breast Cancer Trial Looks to Recruit Underserved Communities : Oncology Times
health disparities:
health disparities
Since the beginning of the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) in 2017, enrollment...
New System Boosted Lung Cancer Surgery by 43% in Black Patients
If surgery for early non–small cell lung cancer (NSCLC) is not performed within 8 weeks of diagnosis, survival outcomes are not as good as they cou...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
